Forbion
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Tropic secures £80m Series C led by Forbion and Corteva for gene-edited tropical crop varieties
Tropic develops gene-edited tropical crop varieties designed to improve disease resistance, shelf life and agricultural productivity. Its products aim to help growers, exporters and food supply chains manage crop disease, reduce waste and increase yields.
PACT secures £15m Series A led by Forbion and HV Capital to scale sustainable collagen-based material
PACT develops collagen-based biomaterials that replace plastic-coated textiles, supplying scalable, supple materials for fashion, interiors and automotive applications using surplus biological inputs.
Elevara raises £50m Series A led by Forbion and Sofinnova Partners to develop therapies for rheumatoid arthritis
Elevara develops oral therapies for rheumatoid arthritis by targeting synovial fibroblasts rather than the immune system, aiming to improve remission rates in chronic inflammatory disease.
CellCentric raises £90m Series C led by RA Capital and Forbion to advance first-in-class cancer drug
CellCentric is developing an oral cancer drug for multiple myeloma that targets a novel biological pathway, with ongoing clinical studies evaluating its use alone and in combination with existing therapies.
Verdiva Bio secures £333.5m Series A led by Forbion and General Atlantic to develop next-gen weight loss therapies
Verdiva Bio develops next-generation obesity and metabolic disease therapies, advancing oral and injectable treatment candidates to improve access, adherence and long-term outcomes.
More venture news
- 12 Mar 2026
TropicTropic secures £80m Series C led by Forbion and Corteva for gene-edited tropical crop varieties
Series CAgriculture - 9 Mar 2026
NscaleNscale raises £1.5bn Series C led by Aker ASA and 8090 Industries to deploy AI infrastructure globally
Series CAI - 29 Jan 2026
AutomataAutomata raises £33m Series C led by Dimension to build the operating layer between physical labs and AI models
Series CLife Sciences